Fingerprint
Dive into the research topics of 'Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
Sakibul Huq, Joshua Casaos, Riccardo Serra, Michael Peters, Yuanxuan Xia, Andy S. Ding, Jeff Ehresman, Jayanidhi N. Kedda, Manuel Morales, Noah L. Gorelick, Tianna Zhao, Wataru Ishida, Alexander Perdomo-Pantoja, Arba Cecia, Chenchen Ji, Ian Suk, David Sidransky, Mariana Brait, Henry Brem, Nicolas Skuli
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations